Nidan, you raise some good questions.
First a few questions for you, regarding your questions and scenario. Are you assuming Anavex be the talk of the investment world with positive top line results for PD? Anavex makes the evening news?
If either of these scenarios then addressing your questions:
Nidan a. Will BP be in denial and attack?
I dont think they will be able to deny the news and science internally or to their shareholders. They are probably watching Anavex right now, and hoping for failure.
Nidan b. Will BP throw money at AVXL or try to partner? (who cares)?
I think this is the most likely, and the one I care the most about LOL! They will attempt a buy out. They have money, AVXL may still be
cheap/undervalued! BPs could be accumulating AVXL as we speak! Many argue that we have poison pills in place. But many would be willing to sell out at $6, doubling or tripling the investment they have been sitting on for years. Dr.Missling has made known his well reasoned thoughts on 'partners'.
Nidan c. Will W/S do an attack on FDA/AVXL/other? Doubtful, imho.
Nidan d. Will the CNS patient public understand that just one treatment has been used to treat multiple CNS diseases and the best is yet to come?
I think word will spread fast. I think the respective communities (Pdd, Rett,?) will get the word out quickly.
Nidan e. Will FDA and other WW regulatory bodies chip in to make this happen or not?
I hope they follow good science and regulatory principles. I dont want to see them bend to political will, because that always leads to unwanted results down the road (possible Biogen + Acu..w/o proof)
